182 related articles for article (PubMed ID: 35207660)
1. Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.
May MR; Rübben A; Lennertz A; Vanstreels L; Leijs M
J Pers Med; 2022 Jan; 12(2):. PubMed ID: 35207660
[TBL] [Abstract][Full Text] [Related]
2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
3. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of flap transplantation combined with vacuum sealing drainage and methylprednisolone and cyclosporine in the treatment of pyoderma gangrenosum.
Hao Y; He J; Zhao Z; Li C; Feng Z
Int Wound J; 2023 May; 20(5):1491-1497. PubMed ID: 36321334
[TBL] [Abstract][Full Text] [Related]
5. Applying Intravenous Immunoglobulin and Negative-Pressure Wound Therapy to Treat Refractory Pyoderma Gangrenosum: A Case Report.
Jin SY; Chen M; Wang FY; Wang F
Int J Low Extrem Wounds; 2021 Jun; 20(2):158-161. PubMed ID: 32734793
[TBL] [Abstract][Full Text] [Related]
6. Clinical management of pyoderma gangrenosum.
Wollina U
Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pyoderma gangrenosum with cyclosporine.
Matis WL; Ellis CN; Griffiths CE; Lazarus GS
Arch Dermatol; 1992 Aug; 128(8):1060-4. PubMed ID: 1497359
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
Hrin ML; Bashyam AM; Huang WW; Feldman SR
Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of pyoderma gangrenosum within a chronic wound following microvascular free-tissue transfer.
Jejurikar SS; Kuzon WM; Cederna PS
J Reconstr Microsurg; 2000 Oct; 16(7):535-9. PubMed ID: 11083392
[TBL] [Abstract][Full Text] [Related]
11. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion.
Turcu G; Ioana Nedelcu R; Teodora Nedelcu I; Hodorogea A; Balaban M; Brinzea A; Nichita L; Gabriela Popp C; Andrada Zurac S; Theodor Andrei R
Exp Ther Med; 2020 Jul; 20(1):38-41. PubMed ID: 32508990
[TBL] [Abstract][Full Text] [Related]
12. "Pyoderma gangrenosum of the breast: A challenging diagnosis".
Cabañas Weisz LM; Vicario Elorduy E; García Gutiérrez JJ
Breast J; 2020 Nov; 26(11):2188-2193. PubMed ID: 32713082
[TBL] [Abstract][Full Text] [Related]
13. Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.
Vallerand IA; Hardin J
SAGE Open Med Case Rep; 2019; 7():2050313X19845206. PubMed ID: 31080598
[TBL] [Abstract][Full Text] [Related]
14. A novel therapy for the treatment of pyoderma gangrenosum.
Azizan NZ; Gangaram HB; Hussein SH
Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
[TBL] [Abstract][Full Text] [Related]
15. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression.
de Imus G; Golomb C; Wilkel C; Tsoukas M; Nowak M; Falanga V
J Am Acad Dermatol; 2001 Jan; 44(1):61-6. PubMed ID: 11148478
[TBL] [Abstract][Full Text] [Related]
16. [Pyoderma gangrenosum and orbital pseudotumor].
Welzel C; Bloching M; Born S; Berghaus A
HNO; 2003 Jun; 51(6):486-91. PubMed ID: 12858856
[TBL] [Abstract][Full Text] [Related]
17. Loose scrotal wound edge approximation in the setting of pyoderma gangrenosum after COVID-19 infection.
Hasan M; Kim Y; Clark JY
Urol Case Rep; 2022 May; 42():102017. PubMed ID: 35136717
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult.
Barry M; AlRajhi A; Aljerian K
Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062748
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum complicating a permanent pacemaker implantation: a case report and literature review.
Frey P; Akret C; Irles D; Dompnier A; Bing AC
Eur Heart J Case Rep; 2020 Apr; 4(2):1-7. PubMed ID: 32352047
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of wound breakdown caused by pyoderma gangrenosum after total knee arthroplasty.
Nakajima N; Ikeuchi M; Izumi M; Kuriyama M; Nakajima H; Tani T
Knee; 2011 Dec; 18(6):453-5. PubMed ID: 20643552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
